Interactive Workshops

Interactive Workshops

60 min interactive workshop sessions, with a group of around 20 people

1. How can we collaborate better to navigate internal conflicting priorities and successfully deliver medicines optimisation projects?

• Identifying the main pressure points within a busy ICB
• How can we support overstretched primary care teams to optimise medicines?
• Exploring new processes that can be implemented to streamline treatment pathways
• Ensuring effective management of all the key stakeholders

Moderator: Selma Abed, Head of Medicines Optimisation, Spirit Healthcare & Mildred Johnson, Clinical Director of Pharmacy & Medicines Optimisation, Maidstone & Tunbridge Wells NHS Trust

** Session in partnership with Spirit Healthcare **

2. Bringing Population Health Management to Life in Cardiovascular Disease

• Striving to deliver population health in a workforce constrained environment
• Driving the LTP prevention agenda including financial and economic outcomes
• Utilising the broader NHS workforce, additional roles (ARRS), and multi-disciplinary approaches
• CVD prevention case study illustration

Moderator: Jyotika Singh, Principal Consultant, Wilmington Healthcare

Key Speaker: Danny Bartlett, Lead Pharmacist, Horsham Central PCN; Senior Lecturer, University of Brighton, Royal Pharmaceutical Society England Board Member

This promotional session has been sponsored by Daiichi Sankyo UK. Daiichi Sankyo UK has had no input or involvement into other event sessions, or the rest of the HSJ ICS Medicines Forum agenda. This session is for UK Healthcare Professionals only, and product information will be discussed.

BEM/23/0723 September 2023

3. How can pharmacy and medicines’ teams take a leading role to close the gap on health inequalities in their communities?

• As systems and roles evolve and settle, how can you best manage the impact of change?
• What should we be doing based on the experience of medicine optimisation teams so far?
• What role can pharmacy take? Driving seat, shot gun or back seat?
• Do we create a new initiative requiring a business case and investment or is it better to piggyback on existing initiatives, or simply scale up the work already being done?
• How should we be utilising and supporting PCN pharmacist resources (and other MDTs) to help close the gap?
• Empowering teams to leverage support from PCNs/ICBs

Through debate and discussion, you will leave with actions you can implement straight away within your ICS

Moderator(s): Meera Parkash, Clinical Facilitator, Population Health Management, Optum UK & Vanessa Burgess, Chief Pharmacist, South East London ICS

**Session in partnership with Optum**

4. Harnessing the power of NHS big data to improve patient outcomes through effective resource utilisation

• Introduction to health economic modelling and its impact
• Understanding various costing and cost projections used
• What are the potential downsides with health economic models and how can we mitigate them?
• Case study to illustrate the process in practice (CPRD-HES; real-world evidence (RWE); phase 4 trial)

Moderators: Andi Orlowski, Director, Health Economics Unit & Sue Thomas, Independent Healthcare Consultant & Tomisin Adedipe, Market Access Manager, BIAL

** Session in partnership with BIAL **